Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluations by the evaluating competent authority, for preparation and submission by the Agency of its opinion and for the Commission to decide whether to renew the approval of K-HDO for use in biocidal products for product-type 8, the expiry date should be postponed to 31 December 2026.
Recital 8, Decision_act (EU) 2022/1488
In forcesince 7 Sep 2022